glp 1 injection reviews Who Should Explore GLP-1 Shots from BodyLogicMD? GLP-1 Pills vs. Injections: Weight

Among patients with UC, those treated with GLP1RA had lower rates of corticosteroid use (39.9% vs 76.0%), emergency department visits (41.9% vs 52.7%), hospitalization (30.6% vs 55.8%), intestinal resection (17.8% vs 53.9%), and mortality (5.8% vs 10.9%)

It is important to note that Wegovy will remain available for eligible Medicare beneficiaries for other FDA-approved indications through their normal Part D benefits, including to reduce the risk of major adverse cardiovascular events in adults with established CV disease with either obesity or overweight

(2019) Sci Rep

Review of Cardiovascular Outcomes Trials of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists